Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, benign, chronic disease characterized by sterile pustular eruption, typically involving the flexural sites of the trunk and proximal extremities.
Features include very common findings: Hyperpigmentation of the skin, Erythema, and Pustule; and common findings: Pruritus. 11 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 4 | Hyperpigmentation of the skin, Pruritus, Systemic lupus erythematosus |
Phenotype severity distribution: 3 very common features, 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for subcorneal pustular dermatosis.
120 publications have been identified in PubMed for subcorneal pustular dermatosis. Research spans Review / Meta-Analysis (65%), Case Report / Case Series (16%), and Epidemiology / Natural History (9%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 68 | 65% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 1:05 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
2 |
Hypothyroidism, Hyperthyroidism |
Lab test results | 2 | Multiple myeloma, Elevated antibody levels (increased circulating immunoglobulin concentration) |
Bones and joints | 1 | Rheumatoid arthritis |
Blood and immune system | 1 | Autoimmunity |
Patient case studies
17 |
16% |
Disease patterns and progression | 9 | 9% |
Laboratory research | 5 | 5% |
Other research | 4 | 4% |
Clinical study results | 2 | 2% |
Kasperkiewicz M (2026). [PMID: 41729378](https://pubmed.ncbi.nlm.nih.gov/41729378/). *Drugs*. [Review / Meta-Analysis]
Altintas A (2026). [PMID: 41691905](https://pubmed.ncbi.nlm.nih.gov/41691905/). *Curr Opin Immunol*. [Review / Meta-Analysis]
Hong S (2026). [PMID: 42176709](https://pubmed.ncbi.nlm.nih.gov/42176709/). *J Am Acad Dermatol*. [Review / Meta-Analysis]
Alhameedy M (2026). [PMID: 42244431](https://pubmed.ncbi.nlm.nih.gov/42244431/). *J Cutan Med Surg*. [Review / Meta-Analysis]
Aslanova M (2026). [PMID: 30085605](https://pubmed.ncbi.nlm.nih.gov/30085605/). *Unknown Journal*. [Other]
Teng YS (2026). [PMID: 41706488](https://pubmed.ncbi.nlm.nih.gov/41706488/). *JAMA Dermatol*. [Other]
Orsillo L (2026). [PMID: 41428840](https://pubmed.ncbi.nlm.nih.gov/41428840/). *R I Med J (2013)*. [Case Report / Case Series]
Mir TH (2026). [PMID: 41740896](https://pubmed.ncbi.nlm.nih.gov/41740896/). *J Am Acad Dermatol*. [Other]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Krusche M (2025). [PMID: 40960635](https://pubmed.ncbi.nlm.nih.gov/40960635/). *Z Rheumatol*. [Review / Meta-Analysis]